Tags
PYFA’s Probiotec Achieves Green Star 6-Star Rating, Reinforcing ESG Commitment in Sustainable Building
JAKARTA, August 11, 2026 — PT Pyridam Farma Tbk (IDX: PYFA), through
Pyridam Farma (PYFA) Records 16.8% Revenue Growth, Operating Loss Shrinks by 99.4% in H1 2026
JAKARTA, July 31, 2026 – PT Pyridam Farma Tbk (IDX: PYFA) recorded
BPOM Inaugurates Ethica Industri Farmasi’s Injection Production Facility, PYFA Ready to Fulfill National Sterile Drug Demand
PYFA Reports 11.8% Sales Growth in Q1 2026, Reinforces Focus on High-Value Products and Capacity Expansion
Pyridam Farma (PYFA) Announces Resignation of President Commissioner Robby Yulianto; New Board to be Unveiled at Upcoming AGM
Protect Your Body from Hantavirus: PYFA Medical Expert Shares Vitamin Recommendations to Boost Immunity
Enhancing Employee Fitness and Solidarity, Pyridam Farma (PYFA) Presents HYROX Through the PYFA Health Sports Community
EGMS Approves Rights Issue, PT Pyridam Farma Tbk (PYFA) Prepares for Strategic Investments and Aggressive Expansion
PYFA Sets Record Net Sales of IDR 2.76 Trillion in Fiscal Year 2025, EBITDA Reaches IDR 203.7 Billion
PYFA Production Facility in Cianjur Officially Certified ISO 45001:2018, Strengthening Its International Standard Management System
Four New Sterile Injection Production Facilities of Ethica Industri Farmasi Ready to Operate and Expand Market Reach
PYFA Supports Mandatory Halal Certification for Pharmaceutical Products, Confirms Ethica Farma Products Are Halal Certified
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
